[go: up one dir, main page]

Kumar-Singh et al., 2000 - Google Patents

[47] Construction of encapsidated (gutted) adenovirus minichromosomes and their application to rescue of photoreceptor degeneration

Kumar-Singh et al., 2000

Document ID
8791095767419416493
Author
Kumar-Singh R
Yamashita C
Tran K
Farber D
Publication year
Publication venue
Methods in enzymology

External Links

Snippet

Publisher Summary This chapter includes all the protocols required to construct and test EAMs with any transgene of interest. A discussion of the main features of the different types of EAMs and of the modified protocols, developed for analysis of EAM-mediated expression …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus

Similar Documents

Publication Publication Date Title
US5994106A (en) Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
Parks et al. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
AU759573B2 (en) Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal DNA of target cells
AU773005B2 (en) Gene therapy to promote angiogenesis
EP0866873B1 (en) Non-group c adenoviral vectors
KR100403708B1 (en) Method for preparing recombinant adeno-associated viruses(aav),and used thereof
JP3755827B2 (en) Integrable recombinant adenoviruses, their production and their therapeutic use
JPH10508491A (en) Novel adenovirus vectors, packaging cell lines, recombinant adenoviruses and methods
US8883493B2 (en) Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
JPH10507927A (en) Improved adenovirus and uses thereof
JPH10506542A (en) Viral vectors and strains for gene therapy
KR19990028307A (en) Recombinant adenovirus, its use for the manufacture of AAV, complementary cell lines and pharmaceutical compositions containing such adenovirus
US6579522B1 (en) Replication deficient adenoviral TNF vector
Shi et al. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors
KR100484441B1 (en) Defective Adenovirus Deactivated IVa2 Gene
Kumar-Singh et al. [47] Construction of encapsidated (gutted) adenovirus minichromosomes and their application to rescue of photoreceptor degeneration
US20040198683A1 (en) Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
MXPA97001766A (en) Defective recombinant adenovirus with a vat iva2 inactiv
Hauser et al. Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy
US8119396B2 (en) Recombinant adenoviral vectors and applications thereof
US7132277B1 (en) Helper dependent vector system for gene therapy
JP2002535986A (en) Improved helper dependent vector system for gene therapy
US20020001579A1 (en) Nonhuman helper-dependent virus vector
WO2000072887A9 (en) A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors
AU703768C (en) Complementary adenoviral vector systems and cell lines